Flash
›
Nurix Therapeutics, Inc. (NRIX) Deep Dive Video
Nurix Therapeutics, Inc. (NRIX) Deep Dive Video
Summary
Nurix Therapeutics offers a cash-backed, clinically leveraged bet on bexobrutideg becoming the first breakthrough BTK degrader, with Roche materially lowering funding risk ahead of pivotal data.
View NRIX stock page
·
Read the NRIX research report
Loading the video player…
Loading Flash…